24,141 Baxter International Inc. $BAX Shares Purchased by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in Baxter International Inc. (NYSE:BAX) by 164.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,826 shares of the medical instruments supplier’s stock after buying an additional 24,141 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Baxter International were worth $932,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Jones Financial Companies Lllp purchased a new stake in Baxter International in the second quarter valued at $26,000. CYBER HORNET ETFs LLC boosted its stake in Baxter International by 52.4% in the second quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock valued at $46,000 after acquiring an additional 740 shares in the last quarter. Community Bank N.A. acquired a new position in Baxter International in the second quarter valued at $46,000. Versant Capital Management Inc boosted its stake in Baxter International by 552.2% in the second quarter. Versant Capital Management Inc now owns 2,413 shares of the medical instruments supplier’s stock valued at $51,000 after acquiring an additional 2,043 shares in the last quarter. Finally, EFG International AG purchased a new position in shares of Baxter International during the second quarter worth about $67,000. 90.19% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have recently commented on BAX shares. Stifel Nicolaus lifted their target price on Baxter International from $19.00 to $24.00 and gave the stock a “hold” rating in a research report on Tuesday, July 28th. Citigroup reduced their target price on Baxter International from $28.00 to $27.00 and set a “neutral” rating for the company in a report on Monday, October 5th. Zacks Research raised Baxter International from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. UBS Group raised their price target on Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a research note on Tuesday, July 28th. Finally, Wells Fargo & Company lifted their price target on Baxter International from $19.00 to $23.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. One analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and a consensus price target of $21.73.

Baxter International Stock Down 1.3%

BAX stock opened at $25.32 on Friday. The company has a fifty day moving average price of $24.76 and a 200 day moving average price of $22.15. Baxter International Inc. has a 12 month low of $15.73 and a 12 month high of $30.00. The company has a market cap of $13.09 billion, a price-to-earnings ratio of 12.51, a price-to-earnings-growth ratio of 3.88 and a beta of 0.65. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.95 and a quick ratio of 1.32.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.19. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The firm had revenue of $2.96 billion during the quarter, compared to analysts’ expectations of $2.80 billion. During the same quarter in the prior year, the business earned $0.59 EPS. Baxter International’s quarterly revenue was up 5.3% compared to the same quarter last year. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. Sell-side analysts expect that Baxter International Inc. will post 2.04 earnings per share for the current year.

Baxter International Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Friday, August 28th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, August 28th. Baxter International’s dividend payout ratio is presently -1.93%.

Baxter International Profile

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.